IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Industrial Biotech

Pressure Builds on the U.S. to Facilitate Biogenerics

10:05 AM MDT | July 26, 2007 | Alex Scott

Almost 50 pro-patient groups in the U.S. representing tens of millions of Americans are pressing the U.S. government to introduce legislation that would facilitate the sale of biologic generic drugs—known as biogenerics or biosimilars, according to the generic pharmaceuticals industry trade group Generic Pharmaceutical Association (GPhA; Arlington, VA). Currently, the U.S. does not have a formal body of legislation to facilitate the market approval of biogenerics. Jaeger: Competition is needed. Congress debated new legislation last week that would enable...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa